aminocaproic acid has been researched along with Leukemia, Myeloid, Acute in 2 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keane, TJ | 1 |
| Gorman, AM | 1 |
| O'Connell, LG | 1 |
| Fennelly, JJ | 1 |
| Schwartz, BS | 1 |
| Williams, EC | 1 |
| Conlan, MG | 1 |
| Mosher, DF | 1 |
2 other studies available for aminocaproic acid and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
epsilon-Amino-caproic acid in the management of acute promyelocytic leukaemia.
Topics: Adult; Aminocaproates; Aminocaproic Acid; Cytarabine; Daunorubicin; Drug Evaluation; Drug Therapy, C | 1976 |
Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.
Topics: alpha-2-Antiplasmin; Aminocaproates; Aminocaproic Acid; Blood Coagulation Disorders; Drug Therapy, C | 1986 |